Complementary and Alternative Medicine
in the Treatment of Anxiety and Depression
Gill van der Watt; Jonathan Laugharne; Aleksandar Janca
Curr Opin Psychiatry. 2008;21(1):37-42. ©2008 Lippincott
Williams & Wilkins. Posted 01/15/2008
Abstract
Purpose of Review: There is well documented
evidence for the increasing widespread use of complementary and alternative
medicine in the treatment of physical and psychiatric symptoms and disorders
within Western populations. Here we provide a review of the recent literature
on evidence for using such interventions in the treatment of anxiety and
depression.
Recent Findings: With regard to herbal
treatments, kava is effective in reducing anxiety symptoms and St John's
wort in treating mild to moderate depression. The association of kava
with hepatotoxicity, however, is a significant concern. Promising data
continue to emerge for the use of omega-3 fatty acids in managing depression.
Evidence for the use of acupuncture in treating anxiety disorders is becoming
stronger, although there is currently minimal empirical evidence for the
use of aromatherapy or mindfulness-based meditation.
Summary: The evidence base for the
efficacy of the majority of complementary and alternative interventions
used to treat anxiety and depression remains poor. Recent systematic reviews
all point to a significant lack of methodologically rigorous studies within
the field. This lack of evidence does not diminish the popularity of such
interventions within the general Western population.
Introduction
Interest in complementary and alternative medicine (CAM)
continues to grow as an increasing number of people, including health
care professionals, look at ways to improve their own lives and those
of others by using a variety of alternatives to conventional medicine.
There are difficulties in reviewing research in CAM because of the diversity
of practices included under the term and the various ways in which it
is applied across different cultures. The World Health Organization refers
to the increase in the use of nonconventional medicine, meaning traditional,
complementary and alternative medicine, in countries all over the world
in its Traditional Medicine Strategy 2002-2005.[1] Some authors group
complementary medicines into herbal remedies (food supplements that include
vitamin preparations and other organic and inorganic substances, such
as omega-3 fatty acids),[2*] whereas others list individual therapies
such as acupuncture, aromatherapy, herbal therapy, homeopathy, iridology,
naturopathy and reflexology under the umbrella of CAM.[3-6,7*,8*,9] There
is ongoing debate regarding the level of evidence required by the scientific
community and appropriate methodological approaches in CAM research, including
the feasibility and complexities of using randomized controlled trials
(RCTs) and difficulties in identifying suitable placebos.[10]
Kessler et al.[11] reported data on the use of complementary
therapies to treat anxiety and depression in the USA, which indicate that
complementary and alternative therapies are used more than conventional
therapies by people with anxiety and severe depression. This large-scale
study found depression, anxiety and insomnia to be among the most common
reasons for people to use complementary therapies. For example, 53.6%
of respondents suffering from severe depression reported using complementary
and alternative medicine for treatment during the 12 months before the
survey.
In the UK, estimates of the proportion of the general
population using CAM range from 14% to 30%[12] and consumer surveys in
other European countries indicate positive public attitudes toward the
use of complementary therapies, with acupuncture being identified as one
of the most popular forms of complementary treatment.[13] The findings
of a large postal survey conducted in Australia[3] showed that people
who were experiencing mild to moderate depression chose self-help strategies
and complementary therapies such as aromatherapy, St John's wort, meditation
and nutritional supplements rather than seeking professional help. In
contrast, those with severe depression were more likely to seek conventional
professional help and did not tend to use complementary therapies.
Here we review recent research in CAM approaches to the
treatment of anxiety and depression, including use of herbal interventions,
nutritional and dietary supplements, acupuncture, light therapy, meditation
and hypnosis.
Anxiety
A number of complementary and alternative interventions
are currently being used to treat anxiety and anxiety disorders. For the
purposes of this review, they will be grouped as follows: herbal interventions,
nutritional supplements and aromatherapy; cognitive interventions, including
mindfulness-based stress reduction (MBSR) and meditation; and physical
interventions such as acupuncture.
Herbal Interventions, Nutritional Supplements and Aromatherapy
Werneke et al.[2*] conducted an extensive database search
and identified 2007 studies of herbal remedies and nutritional supplements
in the treatment of psychiatric disorders. The authors found that kava
(Piper methysticum) was the most researched remedy for anxiety and that
there was good evidence for its anxiolytic effect. A Cochrane review reported
by Pittler and Ernst,[14] which included 11 RCTs involving 645 patients,
showed that kava is the only herbal remedy that has been proven to be
effective in reducing anxiety. All of these trials showed the anxiolytic
effects of kava to be superior to those of placebo. In a recent review,
Ernst[15*] warned that, although it has been shown to be effective in
reducing anxiety, kava cannot be recommended for clinical use because
of an association with hepatotoxicity, which has led to its withdrawal
from the UK market. He emphasized the importance of conducting large,
long-term clinical trials to investigate the effects of herbal medicines,
which are usually moderate and tend to appear after prolonged periods
of use.
Two separate Cochrane reviews investigated the effectiveness
and safety of treating anxiety disorders with valerian and passiflora.
The valerian review[16**] identified one randomized controlled trial involving
36 patients with generalized anxiety disorder that was eligible for inclusion.
This study found that patients taking diazepam experienced significantly
greater improvement in self-reported anxiety symptoms than those in the
valerian and placebo groups, with no significant differences in reported
side effects between the three groups. The other review, also conducted
by Miyasaka et al.,[17**] identified two passiflora versus benzodiazepine
studies eligible for inclusion with a total of 198 participants, but no
findings reached statistical significance. The authors concluded that
there is insufficient evidence available to draw any clear conclusions
regarding the efficacy or safety of either valerian or passiflora in treating
anxiety disorders.
Aromatherapy is concerned with the psychological, physiological
and pharmacological effects of essential oils introduced by means of inhalation,
olfaction and dermal application. The precise definition of aromatherapy,
however, remains problematic. Perry and Perry[18*] consider the terms
essential oil therapy or phyto-essential-pharmacology to be more precise
than aromatherapy, because effects are not necessarily related to the
aromas only. Some practitioners view aromatherapy as holistic medicine,
which treats soul, spirit and body, whereas a small number of research
groups focus on fragrance compounds and essential oils as medicinal agents
and aim to elucidate their modes of action. The pharmacology behind the
actions of most essential oils remains uncertain, however. Buchbauer and
Jirovetz[19] proposed a universal definition of aromatherapy as the therapeutic
use of fragrances or of volatile substances to cure and mitigate or prevent
diseases, infections and indispositions only by means of inhalation, in
the belief that this definition has helped to promote scientific work
on aromatherapy and the biological effects of essential oils.
In their review of reports published in English language
medical journals, Perry and Perry[18*] found only one small open-label
study of aromatherapy in the treatment of psychiatric patients diagnosed
with anxiety and depressive disorders. Aromatherapy was combined with
massage and essential oils were individualized.[20] The study's author
reported that six of the eight participants experienced reduced anxiety
and improved mood over an 8-month period of use. It is not possible, however,
to distinguish whether this improvement was due to massage, the essential
oils chosen, psychotropic medications (which were not standardized), or
other factors. The study is also limited by the lack of a control group.
A recently reported study of the effectiveness of aromatherapy
in the management of anxiety in patients with cancer[21] was carried out
in four cancer centres and a hospice in the UK, where 288 patients with
cancer and with clinical anxiety or depression were randomly assigned
to a 4-week course of aromatherapy massage or usual supportive care. Patients
receiving the aromatherapy massage experienced a significant improvement
in anxiety and depression symptoms after 2 weeks, and this was maintained
at 6 weeks (64% improvement versus 46% in the control group). The difference
between the groups disappeared by 10 weeks after randomization. Self-reported
anxiety improved more for patients receiving aromatherapy than for patients
in the usual care group at 6 and 10 weeks after randomization, whereas
there was no significant difference in the improvement of self-reported
depression between the group receiving aromatherapy massage and the usual
care only arm. Twenty essential oils were used and individualized according
to the therapist's choice of oils considered most appropriate for each
person. The authors did not report which essential oils were used nor
the specific dosages used. The study was unable to demonstrate whether
massage or the essential oils, or both, were responsible for the improvement
in mood and anxiety of patients receiving aromatherapy.
Cognitive Interventions
Toneatto and Nguyen[22] reviewed controlled studies of
MBSR for the treatment of anxiety and depression published before 2007
and found no evidence for the efficacy of MBSR in reliably reducing anxiety
symptoms. The reviewed studies that reported a statistically significant
reduction in anxiety or depression after MBSR did not include an active
control group; positive findings were found only when waiting list or
usual treatment groups were used as controls. The authors suggested that
nonspecific variables may account for improvements in the MBSR-treated
patients and that future studies with improved methodologies are required
to test the specific efficacy of the mindfulness component of the intervention.
Meditation has a long history across many cultures. There
are many types of meditation, all involving techniques for the focusing
of attention. The object of focus can be an image, an idea, a word, a
phrase, or one's breath. In their Cochrane review of RCTs in which meditation
therapy was used as an intervention for anxiety disorder, Krisanaprakornkit
et al.[23**] focused on studies published before 2006 in which meditation
therapy was compared with conventional treatments, including drugs and
other psychological treatments. The review targeted meditation therapies
that used concentrative meditation or mindfulness meditation to treat
anxiety disorders. The two studies eligible for inclusion in the review
included 45 individuals and were conducted in the USA, whereas there were
no eligible studies from Eastern countries such as India and China, where
many meditation techniques originated. The authors were unable to draw
firm conclusions about the effects of meditation in anxiety disorders
because of the small number of eligible studies. They did note that dropout
rates were high in each of the studies reviewed.
In a study published after these two reviews, Lee et
al.[24] investigated the effectiveness of a meditation-based stress management
programme in patients with anxiety disorder. Forty-six patients diagnosed
with anxiety disorders were randomly assigned to either the meditation
programme (MBSR, which included some education on coping with anxiety,
exercise, muscle build up, relaxation and hypnotic suggestion) or the
education programme. The education programme focused on the biological
aspects of anxiety disorder, with no stress management or behaviour techniques
taught. Prescribed medications were not altered during the study. The
duration of the programme was 8 weeks, with 60-min sessions provided weekly.
There were significant decreases in all anxiety scale scores for the meditation
programme group compared with patients on the education programme. No
significant improvement in measures of depression, somatization, or obsessive-compulsive
symptoms was demonstrated. Limitations of the study include the possible
confounding effects of administered medication, the lack of a true placebo
control and the absence of any follow-up data. The authors suggest that
a larger study taking into account the above limitations is needed to
confirm these findings.
Physical Interventions
Acupuncture is a traditional Chinese treatment using
needles which are inserted at specific points of the body and either manipulated
or electrically stimulated. Traditional Chinese theory posits that acupuncture
corrects the imbalances in yin and yang forces that circulate along channels
in the body, and this balance is considered to be essential for good health.
Two recent studies are of interest.
A randomized crossover trial conducted by Gibson et al.[25]
found statistically significant differences between acupuncture and breathing
retraining, in favour of acupuncture, in a small sample of 10 patients
diagnosed with hyperventilation syndrome (HVS). The authors cautioned
that, although there appears to be a beneficial effect of using acupuncture
to treat HVS by reducing anxiety and hyperventilation symptoms, there
may be a carry-over effect after the acupuncture treatment that was not
detected because of the small sample size. They suggest that a two-arm
randomized trial using an acupuncture placebo might be more appropriate
for further investigating the effects of acupuncture on HVS.
Another recently reported RCT evaluated the efficacy
and acceptability of acupuncture for treatment of post-traumatic stress
disorder (PTSD).[26] In all, 84 patients diagnosed with PTSD were randomly
assigned to one of three groups, with one group receiving acupuncture,
another group receiving cognitive-behavioural therapy (CBT) and the third
acting as a wait list control. A total of 61 participants completed the
trial and the results suggest that acupuncture might be useful in reducing
symptoms of PTSD, depression, anxiety and impairment in people diagnosed
with PTSD. Treatment effects in the acupuncture group were similar to
those with the group CBT intervention, and both interventions were superior
to the wait listed control on all measures. Both groups also expressed
high satisfaction with care, and both acupuncture and group CBT were seen
as equally acceptable by participants in treating PTSD. Treatment effects
were maintained for 3 months after the end of treatment in both the acupuncture
and CBT groups. This initial evidence that acupuncture may be effective
and acceptable for treating PTSD suggests that a larger study is indicated
to evaluate this adequately. The authors suggested that a multisite trial
with multiple therapists rather than a single therapist, additional control
groups, treatment validation procedures and blinded outcome assessment
should be considered.
Depression
Complementary and alternative treatments for depression
and depressive disorders discussed in this report are grouped into the
following categories: herbal interventions, nutritional supplements and
aromatherapy; cognitive interventions, including hypnotherapy, CBT and
mindfulness-based cognitive therapy; and physical interventions, including
acupuncture and light therapy.
Herbal Interventions, Nutritional Supplements and Aromatherapy
A recent review reported by Ernst[15*] indicated that
St John's wort (Hypericum perforatum) is the only herbal remedy found
to be effective as a treatment for mild to moderate depression. The author
discussed a previous meta-analysis published in German language by Roder
et al..[27] In five trials involving 2231 patients that compared St John's
wort with conventional antidepressants, Roder et al. found both approaches
to be equally effective. St John's wort was significantly effective when
compared with placebo in 25 trials involving a total of 2129 patients.
Ernst cautioned against using St John's wort with other medications because
it can increase the plasma levels of a range of drugs and there is a possibility
that it can occasionally trigger psychosis in patients who are using selective
serotonin reuptake inhibitors.
Thachil et al.[9] conducted a review of the evidence
for complementary therapies used in depression by searching the literature
for studies on CAM as monotherapy. Nineteen reports were reviewed, yielding
grade 1 evidence (strong evidence from at least one systematic review
of multiple well designed RCTs) for the use St John's wort, tryptophan/5-hydroxytryptophan,
S-adenosyl methionine, inositol and folate in depressive disorders. None
of these findings was conclusively positive, and folate had a significant
effect only when combined with an antidepressant. The review found grade
2 evidence (strong evidence from at least one properly designed RCT of
appropriate size) for the use of saffron in mild to moderate depression,
but the results are inconclusive and large-scale trials are warranted
to investigate further its potential as an effective treatment.
Mischoulon[28**] reported that the results of recent
studies of omega-3 fatty acid supplementation, including the use of eicosapentaenoic
acid (EPA), are promising in treatment of depression. In addition, the
omega-3 fatty acids have been shown to be safe and might be useful in
specific populations, such as the elderly, pregnant or lactating women,
and people with medical co-morbid conditions. A number of controlled trials
and a few open studies have suggested that supplementation with doses
of EPA and docosahexaenoic acid (DHA) that are about five times higher
than the standard dietary intake in the USA may have antidepressant or
mood-stabilizing effects. Mischoulon described as compelling the evidence
for the efficacy and safety of omega-3 fatty acids to treat patients with
depression, but recommended that more well designed controlled trials
be conducted in larger patient populations. He suggested that, although
the data remain inconclusive, patients with mild depression or those who
are unresponsive to conventional antidepressants might be the best candidates
for alternative treatments such as St John's wort and omega-3 fatty acids.
Clayton et al.[29] reviewed the evidence for the rationale
and benefit of omega-3 fatty acids in the treatment of psychiatric disorders
in children and adolescents, and found some evidence of likely benefit
in the treatment of unipolar depression. The authors emphasized the importance
of conducting further well designed research, taking into account the
importance of blinding patients and researchers to treatment and choosing
appropriate placebos and omega-3 fatty acids (EPA and DHA.)
Aromatherapy research was recently reviewed by Perry
and Perry.[18*] They discussed the antidepressant properties of essential
oils such as bergamot (Citrus bergamia) and geranium (Pelargonium graveolens)
in a report offering clinical and neuropharmacological perspectives of
aromatherapy in managing psychiatric disorders. Although some studies
have shown an association between aromatherapy and improvement in mood
in healthy adults, there is a notable lack of methodologically sound trials
in clinically depressed populations. No conclusions can be drawn regarding
the efficacy of aromatherapy in treating depression until such trials
are conducted. The authors arrived at the overall conclusion that, based
on relevant neuropharmacological and limited clinical evidence, aromatherapy
is a treatment with major but relatively unexplored potential in the field
of clinical psychiatry.
Cognitive Interventions
Alladin and Alibhai[30] compared the effectiveness of
the combination of hypnosis and CBT, which they termed cognitive hypnotherapy,
with that of standard CBT in 84 patients with major depression. Patients
were randomly assigned to the two treatment groups, which were run over
16 weeks. The investigators found that treatment outcomes were significantly
enhanced when CBT was combined with hypnotherapy. Patients from both groups
exhibited significant improvements compared with baseline scores, with
greater reductions in depression, anxiety and hopelessness in the cognitive
hypnotherapy group than in the CBT group. This improvement was maintained
at 6 and 12 months of follow up. The authors suggested that further expanded
studies across multiple settings are required to replicate these findings.
In addition, they propose the use of a dismantling design to clarify which
subcomponents of the hypnotherapy intervention are most important.
In their wide-ranging review of complementary treatments
for depression, Pilkington et al.[8*] concluded that two recent trials
suggest that mindfulness-based cognitive therapy, which integrates aspects
of CBT with components of MBSR programmes, may be useful in preventing
relapse in people who have recovered from depression. In more general
terms, the authors found that, although use of complementary medicine
for the management of depression is widespread, there is currently a rather
limited evidence base for the efficacy of CAM treatments compared with
that for antidepressants or CBT, and that the findings reported remain
inconclusive because of small sample sizes, inadequate follow up, limited
information on attrition and lack of blinding.
Physical Interventions
The first systematic review of RCTs investigating the
efficacy of acupuncture in treating depression was that conducted by Leo
and Ligot.[31] They examined nine RCTs, five of which were considered
to be of poor methodological quality, and found that acupuncture tended
to be as effective as antidepressants in treating depression in the limited
studies available for comparison. The authors stated, however, that the
overall evidence remains inconclusive because of the varied methodology
and study designs used, but that further research investigating the use
of acupuncture in treating depression is warranted.
MacPherson and Schroer[32*] attempted to resolve the
problem of variability in application of acupuncture treatment, which
makes it difficult to test the effectiveness of this intervention empirically.
They described acupuncture as a complex intervention because of the difficulty
in precisely defining what the active ingredients are and how they relate
to each other. The authors reported the process of implementing a consensus
method to develop a standardized treatment protocol in preparation for
a RCT of acupuncture to treat depression. Components likely to be essential
to the intervention that would need to be incorporated into the protocol
were identified and rated over two rounds of evaluation by 15 practitioners.
Such standardization is an important step towards improving the methodological
rigour of clinical trials conducted using CAM interventions.
Light therapy is another physical intervention that is
used to treat depression and depressive disorders. It exposes patients
to a bank of bright lights for a variable number of hours per day, usually
between 1 and 3 h. Patients can read or engage in other activities during
the period of exposure. In a recent paper that reviewed CAM therapies
in the treatment of depression in children and adolescents, Jorm et al.[7*]
found good evidence for the efficacy of light therapy in winter depression.
There was no evidence that it would be effective for nonseasonal depression
because of the very limited data available, suggesting that further research
is warranted.
Conclusion
There is significant and growing interest in the use
of CAM to treat psychiatric disorders across Western and non-Western societies.
We review the current evidence regarding CAM treatments for anxiety and
depressive disorders with a focus on recent studies and reviews. With
regard to the use of herbal interventions, kava has efficacy for reducing
anxiety but is linked to hepatotoxicity. St John's wort is the only demonstrably
effective herbal treatment for mild to moderate depression. There are
now some promising published data for the omega-3 fatty acids EPA and
DHA, supporting their role as adjunct treatments in mild to moderate depressive
states. There is currently minimal evidence for the use of pure aromatherapy
in alleviating the symptoms of anxiety or depression, but the evidence
for acupuncture in treating anxiety disorders, including PTSD, is a little
more robust. Regarding cognitive interventions, MBSR currently has very
little empirical basis but initial research into the combination of hypnotherapy
with CBT appears promising in treating depression.
The well documented popularity of CAM interventions for
anxiety and depression is not reflected in the current evidence base,
which is very limited. There is a paucity of high-quality studies in the
field. Until a reasonable number of methodologically sound studies are
completed across these varied treatment modalities, it will remain difficult
to draw any substantive conclusions regarding their usefulness to the
clinician.
References
Papers of particular interest, published within the annual
period of review, have been highlighted as:
* of special interest
** of outstanding interest
1. World Health Organization. WHO traditional medicines
strategy 2002-2005. Geneva, Switzerland: World Health Organization; 2002.
2. * Werneke U, Turner T, Priebe S. Complementary medicines in psychiatry.
Br J Psychiatry 2006; 188:109-121.
3. Jorm AF, Korten AE, Christensen H, et al. Association of obesity with
anxiety, depression and emotional well being: a community survey. Aust
N Z J Public Health 2003; 27:434-440.
4. MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence
of alternative medicine. Prevent Med 2002; 35:166-173.
5. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine
use in the United States, 1990-1997. JAMA 1998; 280:1569-1575.
6. Thomas K, Fall M, Nicholl J, et al. Methodological study to investigate
the feasibility of conducting a population-based survey of the use of
complementary healthcare. London, UK: Research Council for Complementary
Medicine; 1993.
7. * Jorm AF, Allen NB, O'Donnell CP, et al. Effectiveness of complementary
and self-help treatments for depression in children and adolescents. Med
J Aust 2006; 185:368-372. The authors provide a systematic review of the
limited evidence for complementary treatments of depression within a population
for which the role of conventional antidepressant medication remains controversial.
8. * Pilkington K, Rampes H, Richardson J. Complementary medicine for
depression. Expert Rev Neurother 2006; 6:1741-1751. This concise but wide-ranging
review of CAM treatments for depression also addresses issues of future
research design.
9. Thachil AF, Mohan R, Bhugra D. The evidence base of complementary and
alternative therapies in depression. J Affect Dis 2007; 97:23-35.
10. Richardson J. The use of randomized control trials in complementary
therapies: exploring the issues. J Adv Nurs 2000; 32:398-406.
11. Kessler RC, Soukup J, Davis RB, et al. The uses of complementary and
alternative therapies to treat anxiety and depression in the United States.
Am J Psychiatry 2001; 158:289-294.
12. Sharma U. Complementary medicine today: practitioners and patients.
London, UK: Routledge; 1992.
13. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994; 309:107-111.
14. Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database
Syst Rev 2003; 1:CD003383.
15. * Ernst E. Herbal remedies for depression and anxiety. Adv Psychiatr
Treat 2007; 13:312-316. This is a very useful recent summary of the evidence
for the use of herbal remedies in treating depression and anxiety by an
international leader in the field.
16. ** Miyasaka LS, Atallah AN, Soares BG. Valerian for anxiety disorders.
Cochrane Database Syst Rev 2006; 4:CD004515. This paper and [17**]
17. ** Miyasaka LS, Atallah AN, Soares BG. Passiflora for anxiety disorder.
Cochrane Database Syst Rev 2007; 1:CD004518. This paper and [16**]
18. * Perry N, Perry E. Aromatherapy in the management of psychiatric
disorders: clinical and neuropharmacological perspectives. CNS Drugs 2006;
20:257-280. The authors' comprehensive review of the aromatherapy literature
with regard to psychiatric conditions includes a useful discussion of
the methodological challenges in conducting high-quality studies on aromatherapy.
19. Buchbauer G, Jirovetz L. Aromatherapy: use of fragrances and essential
oils as medicants. Flavour Fragrance J 1994; 9:217-222.
20. Edge J. A pilot study addressing the effect of aromatherapy massage
on mood, anxiety and relaxation in adult mental health. Complement Ther
Nurs Midwifery 2003; 9:90-97.
21. Wilkinson SM, Love SB, Westcombe AM, et al. Effectiveness of aromatherapy
massage in the management of anxiety and depression in patients with cancer:
a multicenter randomized controlled trial. J Clin Oncol 2007; 25:532-539.
22. Toneatto TT, Nguyen LL. Does mindfulness meditation improve anxiety
and mood symptoms? A review of the controlled research. Can J Psychiatry
2007; 52:260-266.
23. ** Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, et al.
Meditation therapy for anxiety disorders. Cochrane Database Syst Rev 2007;
3:CD004998. This rigorous systematic review found only two RCTs of meditation-based
therapy for anxiety disorders, neither of which were of high quality.
The current evidence base is thus shown to be weak and a high dropout
rate is highlighted.
24. Lee SH, Ahn SC, Lee YJ, et al. Effectiveness of a meditation-based
stress management program as an adjunct to pharmacotherapy in patients
with anxiety disorder. J Psychosom Res 2007; 62:189-195.
25. Gibson D, Bruton A, Lewith GT, et al. Effects of acupuncture as a
treatment for hyperventilation syndrome a pilot, randomized crossover
trial. J Altern Complement Med 2007; 13:39-46.
26. Hollifield M, Sinclair-Lian N, Warner TD, Hammerschlag R. Acupuncture
for posttraumatic stress disorder: a randomized controlled pilot trial.
J Nerv Ment Dis 2007; 195:504-513.
27. John's Wort [in German]. Fortschr Neurol Psychiatr 2004; 72:330-343.
28. ** Mischoulon D. Update and critique of natural remedies as antidepressant
treatments. Psychiatr Clin North Am 2007; 30:51-68. This is a particularly
informative recent review of evidence for the antidepressant properties
of St John's wort, S-adenosyl methionine and the omega-3 fatty acids.
29. Clayton EH, Hanstock TL, Garg ML, Hazell PL. Long chain omega-3 polyunsaturated
fatty acids in the treatment of psychiatric illnesses in children and
adolescents. Acta Neuropsychiatr 2007; 19:92-103.
30. Alladin A, Alibhai A. Cognitive hypnotherapy for depression: an empirical
investigation. Int J Clin Exp Hypnosis 2007; 55:147-166.
31. Leo RJ, Ligot A. A systematic review of randomised controlled trials
of acupuncture in the treatment of depression. J Affect Dis 2007; 97:13-22.
32. * MacPherson H, Schroer S. Acupuncture as a complex intervention for
depression: a consensus method to develop a standardised treatment protocol
for a randomised controlled trial. Complement Ther Med 2007; 15:92-100.
One of the difficulties in CAM research is the standardization of interventions,
and this paper offers a useful approach to standardizing an acupuncture
treatment protocol that will improve the quality of further research in
the field. |